Restore Medical

Revolution in heart failure — the first transcatheter Pulmonary Artery Banding system

Headquarters
Or-Yehuda
Employees
1–10
Business Model
B2B
Last Round
Series BDec 2024
Rounds
1

About

Restore Medical is a privately held Israeli clinical-stage medical device company dedicated to transforming the treatment of congestive heart failure (CHF). The company has developed ContraBand™, the first and only transcatheter Pulmonary Artery Banding (PAB) system for treating HFrEF (Heart Failure with reduced Ejection Fraction) patients. ContraBand is a reversible, catheter-delivered implant that leverages the right ventricle to support the left ventricle, improving LV ejection fraction and restoring optimal ventricular geometry. The device received FDA Breakthrough Device Designation in July 2024. Restore Medical secured $23M in funding in 2025 and previously received €2.5M in EU funding plus a €10M EIC equity commitment.

Summary

Restore Medical is a Healthcare company based in Or-Yehuda, Israel. Its most recent funding was a Series B round in Dec 2024. Investors include Pitango Growth, European Innovation Council Fund and Peregrine Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BDec 2024

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Restore Medical on Indexed.vc
<a href="https://indexed.vc/companies/restore-medical"><img src="https://indexed.vc/api/badge/company/restore-medical" alt="Restore Medical on Indexed.vc" width="260" height="76" /></a>